Gabrielle (Gabi) Ndakwah is an MD-PhD student from the Metro Detroit area. She earned her Bachelors of Science (SB) from Massachusetts Institute of Technology in Biological Engineering, where she worked in Robert Langer’s lab on drug delivery of combination cancer therapeutics. Thereafter, she transitioned to working on vector design of in vivo CAR-T cell therapeutics at Kelonia Therapeutics, now merged with Eli Lilly and Co. Gabi is coadvised with PJ Utz in Immunology and Rheumatology, and is currently interrogating the role of autoantibodies in pregnancy-related disease against glycoproteins and interested in development of antibody-targeting therapeutics within women’s health. Outside of lab, Gabi is very active and can be found running the streets and trails of the Bay Area with her dog, Genie; weightlifting; doing yoga; or baking to provide energy for her endless escapades.
